COSCIENS Biopharma (CSCI)
NASDAQ:CSCI
Holding CSCI?
Track your performance easily

COSCIENS Biopharma (CSCI) Financial Statements

906 Followers

COSCIENS Biopharma Financial Overview

COSCIENS Biopharma's market cap is currently ―. The company's EPS TTM is $-29.083; its P/E ratio is -0.21; COSCIENS Biopharma is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 4.00K$ 121.00K$ 3.00K$ 2.25M$ 2.13M
Gross Profit$ -12.00K$ 288.00K$ -8.00K$ 2.11M$ 2.11M
EBIT$ -5.75M$ -5.64M$ -4.14M$ -2.52M$ -4.25M
EBITDA$ -5.70M$ -5.65M$ -4.10M$ -3.27M$ -4.97M
Net Income Common Stockholders$ -5.75M$ -5.63M$ -4.14M$ -2.52M$ -4.25M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 29.55M$ 34.02M$ 38.76M$ 42.19M$ 46.56M
Total Assets$ 31.79M$ 37.02M$ 42.49M$ 46.48M$ 51.28M
Total Debt$ 234.00K$ 279.00K$ 217.00K$ 230.00K$ 210.00K
Net Debt$ -29.31M$ -33.74M$ -38.54M$ -41.96M$ -46.35M
Total Liabilities$ 18.82M$ 18.82M$ 16.21M$ 17.40M$ 20.07M
Stockholders Equity$ 12.97M$ 18.20M$ 26.28M$ 29.08M$ 31.21M
Cash Flow-
Free Cash Flow$ -4.29M$ -5.38M---
Operating Cash Flow$ -4.29M$ -5.38M$ -3.38M$ -4.29M$ -4.06M
Investing Cash Flow$ -5.00K$ 543.00K$ -10.00K$ -3.00K$ -2.00K
Financing Cash Flow$ -42.00K$ -38.00K$ -33.00K$ -42.00K$ -38.00K
Currency in USD

COSCIENS Biopharma Earnings and Revenue History

COSCIENS Biopharma Debt to Assets

COSCIENS Biopharma Cash Flow

COSCIENS Biopharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis